These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17211228)

  • 1. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
    Calò LA; Pessina AC
    J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
    Jin L; Burnett AL
    Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
    Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RhoA/Rho kinase pathway in the myocardium.
    Peters SL; Michel MC
    Cardiovasc Res; 2007 Jul; 75(1):3-4. PubMed ID: 17499228
    [No Abstract]   [Full Text] [Related]  

  • 6. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
    Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
    Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
    Jalil J; Lavandero S; Chiong M; Ocaranza MP
    Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
    Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
    Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle.
    Somlyo AP; Somlyo AV
    J Muscle Res Cell Motil; 2004; 25(8):613-5. PubMed ID: 15750846
    [No Abstract]   [Full Text] [Related]  

  • 12. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
    Hu E; Lee D
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule depolymerization facilitates contraction of vascular smooth muscle via increased activation of RhoA/Rho-kinase.
    Chitaley K; Webb RC
    Med Hypotheses; 2001 Mar; 56(3):381-5. PubMed ID: 11359365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase.
    Bolz SS; Vogel L; Sollinger D; Derwand R; Boer C; Pitson SM; Spiegel S; Pohl U
    Circulation; 2003 Jul; 108(3):342-7. PubMed ID: 12847068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase is an important therapeutic target in cardiovascular medicine.
    Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
    Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
    Budzyn K; Marley PD; Sobey CG
    Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
    Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
    J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells.
    Sugimoto M; Nakayama M; Goto TM; Amano M; Komori K; Kaibuchi K
    Biochem Biophys Res Commun; 2007 Sep; 361(2):462-7. PubMed ID: 17651694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons.
    Zhang Y; Gu X; Yuan X
    Eur J Neurosci; 2007 Mar; 25(5):1341-8. PubMed ID: 17425560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.